secwatch.observer — SEC 8-K summary
======================================

Issuer:     ILLUMINA, INC. (ILMN)
CIK:        0001110803
Form:       8-K
Filed at:   2024-04-09T23:59:59+00:00
Accession:  0000950157-24-000591
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Illumina names Ankur Dhingra CFO; Joydeep Goswami departs; Q1/FY24 guidance reaffirmed
--------------------------------------------------------------------------------

- Ankur Dhingra appointed CFO effective April 15, 2024; previously CFO of Summit Therapeutics (SMMT) and CareDx.
- Joydeep Goswami leaves Illumina, stays as advisor through June 30; departure not due to disagreement.
- Jakob Wedel named Chief Strategy and Corporate Development Officer, effective immediately.
- Dhingra receives $650k base salary, $500k cash sign-on, $3.5M equity grant (70% PSUs, 30% RSUs), $15k monthly travel stipend.
- Illumina reaffirms Q1 2024 and full-year 2024 financial guidance as announced on February 8, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1110803/000095015724000591/0000950157-24-000591-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1110803/000095015724000591/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0000950157-24-000591

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer